Sellas Life Sciences Group Inc (SLS)

$1.47 0.00 (0.00%)

16:00 EDT SLS Stock Quote Delayed 30 Minutes

SLS Stock Earnings: SELLAS Life Sciences Gr Misses EPS for Q1 2024

By InvestorPlace Earnings May 14, 2024

SLS stock results show that SELLAS Life Sciences Gr missed analyst estimates for earnings per share the first quarter of 2024.

SLS Stock Earnings: SELLAS Life Sciences Gr Misses EPS for Q4 2023

Why Is Sellas Life Sciences (SLS) Stock Down 25% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

More Articles

Volume:

Previous Close -

Market Cap 23.33M

PE Ratio -1.34

EPS -1.1

Volume (Avg. Vol.) 1.29M

Day's Range $1.42 - $1.54

52-Week Range $0.50 - $1.91

Dividend & Yield N/A (N/A)

SLS Stock Predictions, Articles, and Sellas Life Sciences Group Inc News

From InvestorPlace
From the Web

Why Is SELLAS Life Sciences (SLS) Stock Down 38% Today?

By William White, InvestorPlace Writer Feb 24, 2023

SELLAS Life Sciences (SLS) stock is falling on Friday after the biopharmaceutical company announced a proposed public offering.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Feb 24, 2023

It's time to start off trading on Friday with a breakdown of the biggest pre-market stock movers worth keeping an eye on!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Oct 12, 2022

It's time for another dive into the biggest pre-market stock movers as we check out what's behind shares moving on Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer May 19, 2022

It's time to tackle the biggest pre-market stock movers for this morning as we get ready for trading hours to start on Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Apr 6, 2022

Good morning! Another day of trading lies ahead and we're starting it off with the biggest pre-market stock movers for Wednesday!

SLS Stock: 8 Things to Know About SELLAS Life Sciences as It Enjoys Reddit Bump

By Nick Clarkson, Web Editor Feb 3, 2021

Shares of SLS stock are up after SELLAS Life Sciences was mentioned heavily on Reddit. Who is this company? Let's take a deeper dive.

SLS Stock: Why SELLAS Life Sciences Is Surging Today

By Sarah Smith, Editor-in-Chief, InvestorPlace.com Dec 10, 2020

SLS stock is surging today as investors grow interest in a cancer vaccine from SELLAS Life Sciences in the wake of a rally in GLSI stock.

Sellas Life Sciences gains on securing orphan drug status for r/r PTCL treatment

From Seeking Alpha Jan 11, 2024

Sellas Life Sciences shares surge as its CDK9 inhibitor, SLS009, gains FDA orphan drug designation for treating relapsed or refractory lymphomas and acute...

Sellas Life Sciences gains after leukemia therapy gets FDA fast track status (NASDAQ:SLS)

From Seeking Alpha Jan 9, 2024

Sellas Life Sciences gains FDA fast track designation for its innovative AML treatment, showing promising anti-leukemic effects with a favorable safety...

SELLAS Life Sciences announces pricing of $9M public offering (NASDAQ:SLS)

From Seeking Alpha Jan 4, 2024

SELLAS Life Sciences Group announces a public offering of 12M shares of common stock and warrants, expected to close on January 8, 2024.

SELLAS Life Sciences announces launch of proposed public offering

From Seeking Alpha Jan 4, 2024

SELLAS Life Sciences (SLS) on Wednesday announced a proposed underwritten public offering in which it intends to offer and sell shares of its common stock and an accompanying warrant to..

SELLAS Life Sciences Group (SLS) Gets a Buy from Maxim Group

From TipRanks Nov 15, 2022

Maxim Group analyst Jason McCarthy reiterated a Buy rating on SELLAS Life Sciences Group (SLS – Research Report) yesterday and set a price target of $12.00. T...

SELLAS Craters After Postponing Cancer Drug Milestone

From TipRanks Nov 14, 2022

Shares of SELLAS Life Sciences Group (NASDAQ: SLS) were in a downward spiral on Monday morning as the late-stage clinical biopharmaceutical company announced a busi...

ADVERTISEMENT